Reversible Pisa syndrome in Parkinson's disease during treatment with pergolide: A case report [1]
2005-01-01 Cannas, A.; Solla, P.; Floris, G.; Borghero, G.; Tacconi, P.; Spissu, A.
Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications
2011-01-01 Solla, P.; Cannas, A.; Floris, G. L.; Orofino, G.; Costantino, E.; Boi, A.; Serra, C.; Marrosu, M. G.; Marrosu, F.
Mucuna pruriens(Velvet bean) rescues motor, olfactory, mitochondrial and synaptic impairment in PINK1B9 Drosophila melanogaster genetic model of Parkinson's disease
2014-01-01 Poddighe, S.; De Rose, F.; Marotta, R.; Ruffilli, R.; Fanti, M.; Secci, P. P.; Mostallino, M. C.; Setzu, M. D.; Zuncheddu, M. A.; Collu, I.; Solla, P.; Marrosu, F.; Kasture, S.; Acquas, E.; Liscia, A.
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel
2015-01-01 Solla, P.; Cannas, A.; Marrosu, M. G.; Marrosu, F.
Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease
2012-01-01 Solla, P.; Cannas, A.; Ibba, F. C.; Loi, F.; Corona, M.; Orofino, G.; Marrosu, M. G.; Marrosu, F.
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study
2014-01-01 Tinazzi, M.; Morgante, F.; Matinella, A.; Bovi, T.; Cannas, A.; Solla, P.; Marrosu, F.; Nicoletti, A.; Zappia, M.; Luca, A.; Di Stefano, A.; Morgante, L.; Pacchetti, C.; Minafra, B.; Sciarretta, M.; Dallocchio, C.; Rossi, S.; Ulivelli, M.; Ceravolo, R.; Frosini, D.; Cipriani, A.; Barbui, C.
Rasagiline and Pisa syndrome in Parkinson’s disease patients
2015-01-01 Solla, P.; Cannas, A.; Orofino, G.; Marrosu, F.
Influence of Parkinsonism on Hitler's Decision-Making
2016-01-01 Solla, P.; Cannas, A.; Marrosu, F.
Pisa syndrome in Parkinson disease
2015-01-01 Tinazzi, M.; Fasano, A.; Geroin, C.; Morgante, F.; Ceravolo, R.; Rossi, S.; Thomas, A.; Fabbrini, G.; Bentivoglio, A.; Tamma, F.; Cossu, G.; Modugno, N.; Zappia, M.; Volonte, M. A.; Dallocchio, C.; Abbruzzese, G.; Pacchetti, C.; Marconi, R.; Defazio, G.; Canesi, M.; Cannas, A.; Pisani, A.; Mirandola, R.; Barone, P.; Vitale, C.; Allocca, R.; Altavilla, T.; Bisoffi, G.; Bombieri, F.; Bove, F.; Bovi, T.; Cerbarano, L.; Cordano, C.; Di Giacomo, R.; Di Stefano, F.; Erro, R.; Gallerini, S.; Gandolfi, M.; Gigante, A. F.; Juergenson, I.; Lena, F.; Leocani, L. M.; Lucchese, V.; Madeo, G.; Mazzucchi, S.; Moccia, M.; Nicoletti, A.; Ottaviani, S.; Pezzoli, G.; Santangelo, G.; Sarchioto, M.; Schena, F.; Sciarretta, M.; Smania, N.; Solla, P.; Spagnolo, F.; Ulivelli, M.
Focal (123)I-FP-CIT SPECT Abnormality in Midbrain Vascular Parkinsonism
2015-01-01 Solla, Paolo; Cannas, Antonino; Arca, Roberta; Fonti, Davide; Orofino, Gianni; Marrosu, Francesco
Frequency and determinants of olfactory hallucinations in parkinson’s disease patients
2021-01-01 Solla, P.; Masala, C.; Pinna, I.; Ercoli, T.; Loy, F.; Orofino, G.; Fadda, L.; Defazio, G.
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder
2021-01-01 Sechi, E.; Zarbo, R.; Biancu, M. A.; Chessa, P.; Idda, M. L.; Orru, V.; Lai, S.; Leoni, S.; Solla, P.
Qualitative smell/taste disorders as sequelae of acute COVID-19
2021-01-01 Ercoli, T.; Masala, C.; Pinna, I.; Orofino, G.; Solla, P.; Rocchi, L.; Defazio, G.
Exposure to TNF inhibitors is rare at MOGAD presentation
2022-01-01 Redenbaugh, V.; Flanagan, E. P.; Floris, V.; Zara, P.; Bhatti, M. T.; Sanchez, F.; Koster, M.; Mariotto, S.; Pittock, S. J.; Chen, J. J.; Cauli, A.; Solla, P.; Sechi, E.
Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI
2021-01-01 Zara, P.; Floris, V.; Flanagan, E. P.; Lopez-Chiriboga, A. S.; Weinshenker, B. G.; Solla, P.; Sechi, E.
Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease
2021-01-01 Bachetti, T.; Zanni, E. D.; Adamo, A.; Rosamilia, F.; Sechi, M. M.; Solla, P.; Bozzo, M.; Ceccherini, I.; Sechi, G.
Chronic inflammatory demyelinating polyneuropathy after chadox1 ncov-19 vaccination
2021-01-01 Bagella, C. F.; Corda, D. G.; Zara, P.; Elia, A. E.; Ruiu, E.; Sechi, E.; Solla, P.
Olfactory Impairment in Parkinson’s Disease Patients with Tremor Dominant Subtype Compared to Those with Akinetic Rigid Dominant Subtype: A Pilot Study
2022-01-01 Solla, P.; Masala, C.; Ercoli, T.; Orofino, G.; Loy, F.; Pinna, I.; Fadda, L.; Defazio, G.
Rasagiline Withdrawal Syndrome in Parkinson’s Disease
2022-01-01 Solla, P.; Ercoli, T.; Masala, C.; Orofino, G.; Fadda, L.; Corda, D. G.; Zarbo, I. R.; Meloni, M.; Sechi, E.; Bagella, C. F.; Defazio, G.
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD
2022-01-01 Dinoto, A.; Sechi, E.; Ferrari, S.; Gajofatto, A.; Orlandi, R.; Solla, P.; Maccabeo, A.; Maniscalco, G. T.; Andreone, V.; Sartori, A.; Manganotti, P.; Rasia, S.; Capra, R.; Mancinelli, C. R.; Mariotto, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Reversible Pisa syndrome in Parkinson's disease during treatment with pergolide: A case report [1] | 1-gen-2005 | Cannas, A.; Solla, P.; Floris, G.; Borghero, G.; Tacconi, P.; Spissu, A. | |
| Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications | 1-gen-2011 | Solla, P.; Cannas, A.; Floris, G. L.; Orofino, G.; Costantino, E.; Boi, A.; Serra, C.; Marrosu, M. G.; Marrosu, F. | |
| Mucuna pruriens(Velvet bean) rescues motor, olfactory, mitochondrial and synaptic impairment in PINK1B9 Drosophila melanogaster genetic model of Parkinson's disease | 1-gen-2014 | Poddighe, S.; De Rose, F.; Marotta, R.; Ruffilli, R.; Fanti, M.; Secci, P. P.; Mostallino, M. C.; Setzu, M. D.; Zuncheddu, M. A.; Collu, I.; Solla, P.; Marrosu, F.; Kasture, S.; Acquas, E.; Liscia, A. | |
| Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel | 1-gen-2015 | Solla, P.; Cannas, A.; Marrosu, M. G.; Marrosu, F. | |
| Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease | 1-gen-2012 | Solla, P.; Cannas, A.; Ibba, F. C.; Loi, F.; Corona, M.; Orofino, G.; Marrosu, M. G.; Marrosu, F. | |
| Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study | 1-gen-2014 | Tinazzi, M.; Morgante, F.; Matinella, A.; Bovi, T.; Cannas, A.; Solla, P.; Marrosu, F.; Nicoletti, A.; Zappia, M.; Luca, A.; Di Stefano, A.; Morgante, L.; Pacchetti, C.; Minafra, B.; Sciarretta, M.; Dallocchio, C.; Rossi, S.; Ulivelli, M.; Ceravolo, R.; Frosini, D.; Cipriani, A.; Barbui, C. | |
| Rasagiline and Pisa syndrome in Parkinson’s disease patients | 1-gen-2015 | Solla, P.; Cannas, A.; Orofino, G.; Marrosu, F. | |
| Influence of Parkinsonism on Hitler's Decision-Making | 1-gen-2016 | Solla, P.; Cannas, A.; Marrosu, F. | |
| Pisa syndrome in Parkinson disease | 1-gen-2015 | Tinazzi, M.; Fasano, A.; Geroin, C.; Morgante, F.; Ceravolo, R.; Rossi, S.; Thomas, A.; Fabbrini, G.; Bentivoglio, A.; Tamma, F.; Cossu, G.; Modugno, N.; Zappia, M.; Volonte, M. A.; Dallocchio, C.; Abbruzzese, G.; Pacchetti, C.; Marconi, R.; Defazio, G.; Canesi, M.; Cannas, A.; Pisani, A.; Mirandola, R.; Barone, P.; Vitale, C.; Allocca, R.; Altavilla, T.; Bisoffi, G.; Bombieri, F.; Bove, F.; Bovi, T.; Cerbarano, L.; Cordano, C.; Di Giacomo, R.; Di Stefano, F.; Erro, R.; Gallerini, S.; Gandolfi, M.; Gigante, A. F.; Juergenson, I.; Lena, F.; Leocani, L. M.; Lucchese, V.; Madeo, G.; Mazzucchi, S.; Moccia, M.; Nicoletti, A.; Ottaviani, S.; Pezzoli, G.; Santangelo, G.; Sarchioto, M.; Schena, F.; Sciarretta, M.; Smania, N.; Solla, P.; Spagnolo, F.; Ulivelli, M. | |
| Focal (123)I-FP-CIT SPECT Abnormality in Midbrain Vascular Parkinsonism | 1-gen-2015 | Solla, Paolo; Cannas, Antonino; Arca, Roberta; Fonti, Davide; Orofino, Gianni; Marrosu, Francesco | |
| Frequency and determinants of olfactory hallucinations in parkinson’s disease patients | 1-gen-2021 | Solla, P.; Masala, C.; Pinna, I.; Ercoli, T.; Loy, F.; Orofino, G.; Fadda, L.; Defazio, G. | |
| Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder | 1-gen-2021 | Sechi, E.; Zarbo, R.; Biancu, M. A.; Chessa, P.; Idda, M. L.; Orru, V.; Lai, S.; Leoni, S.; Solla, P. | |
| Qualitative smell/taste disorders as sequelae of acute COVID-19 | 1-gen-2021 | Ercoli, T.; Masala, C.; Pinna, I.; Orofino, G.; Solla, P.; Rocchi, L.; Defazio, G. | |
| Exposure to TNF inhibitors is rare at MOGAD presentation | 1-gen-2022 | Redenbaugh, V.; Flanagan, E. P.; Floris, V.; Zara, P.; Bhatti, M. T.; Sanchez, F.; Koster, M.; Mariotto, S.; Pittock, S. J.; Chen, J. J.; Cauli, A.; Solla, P.; Sechi, E. | |
| Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI | 1-gen-2021 | Zara, P.; Floris, V.; Flanagan, E. P.; Lopez-Chiriboga, A. S.; Weinshenker, B. G.; Solla, P.; Sechi, E. | |
| Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease | 1-gen-2021 | Bachetti, T.; Zanni, E. D.; Adamo, A.; Rosamilia, F.; Sechi, M. M.; Solla, P.; Bozzo, M.; Ceccherini, I.; Sechi, G. | |
| Chronic inflammatory demyelinating polyneuropathy after chadox1 ncov-19 vaccination | 1-gen-2021 | Bagella, C. F.; Corda, D. G.; Zara, P.; Elia, A. E.; Ruiu, E.; Sechi, E.; Solla, P. | |
| Olfactory Impairment in Parkinson’s Disease Patients with Tremor Dominant Subtype Compared to Those with Akinetic Rigid Dominant Subtype: A Pilot Study | 1-gen-2022 | Solla, P.; Masala, C.; Ercoli, T.; Orofino, G.; Loy, F.; Pinna, I.; Fadda, L.; Defazio, G. | |
| Rasagiline Withdrawal Syndrome in Parkinson’s Disease | 1-gen-2022 | Solla, P.; Ercoli, T.; Masala, C.; Orofino, G.; Fadda, L.; Corda, D. G.; Zarbo, I. R.; Meloni, M.; Sechi, E.; Bagella, C. F.; Defazio, G. | |
| Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD | 1-gen-2022 | Dinoto, A.; Sechi, E.; Ferrari, S.; Gajofatto, A.; Orlandi, R.; Solla, P.; Maccabeo, A.; Maniscalco, G. T.; Andreone, V.; Sartori, A.; Manganotti, P.; Rasia, S.; Capra, R.; Mancinelli, C. R.; Mariotto, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista37499
Data di pubblicazione
- In corso di stampa63
- 2020 - 20268878
- 2010 - 201912729
- 2000 - 20098932
- 1990 - 19994656
- 1980 - 19891792
- 1970 - 1979438
- 1965 - 196911
Editore
- Diritto @ storia220
- Gallizzi162
- Università degli studi di Sassari...160
- Public Library of Science135
- BioMed Central105
- Avenue media on behalf of Scienti...98
- Università degli studi di Sassari...79
- Università degli studi di Sassari...61
- Edagricole46
- Università degli studi di Sassari...45
Rivista
- DIRITTO@STORIA401
- PHYSICAL REVIEW D, PARTICLES, FIE...292
- PHYSICAL REVIEW LETTERS290
- STUDI SASSARESI. SEZIONE 3: ANNAL...283
- PLOS ONE279
- BOLLETTINO DELLA SOCIETÀ SARDA DI...178
- BIOLOGIA MARINA MEDITERRANEA156
- SANDALION153
- ANIMALS151
- SCIENTIFIC REPORTS146
Keyword
- Humans701
- Sardinia639
- Sardegna417
- Female354
- Italy333
- Male320
- COVID-19286
- Middle Aged219
- Adult180
- SARS-CoV-2169
Lingua
- eng23474
- ita9497
- fre244
- spa169
- ger80
- lat31
- und28
- rus23
- por16
- cat14
Accesso al fulltext
- no fulltext33385
- open3617
- reserved293
- restricted136
- partially open66
- mixed2